Fragment-Based Drug Discovery Solutions Market is Expected to Reach 1.6 billion by 2030


Posted July 15, 2020 by charlottefraser21

Over 85 firms are involved in providing fragment-based drug discovery-related services; of these, around 40 players claim to offer both libraries and technologies

 
According to experts in this field, Fragment-Based Drug Discovery Solutions have facilitated the identification of viable pharmacological leads against otherwise hard to target biomolecules. In fact, many service provider companies are offering fragment libraries and support to the medical research community in order to develop an appropriate intervention to treat the illness caused by the SARS-CoV-2 virus.

The USD 1.6 billion (by 2030) financial opportunity within the fragment-based drug discovery market has been analyzed across the following segments:

Key Market Insights

Type of Screening Technique Used
• X-ray Crystallography
• Nuclear Magnetic Resonance
• Surface Plasmon Resonance
• Other Screening Techniques

Type of Service Offered
• Library Screening
• Fragment Screening
• Fragment Optimization

End User
• Industry Players
• Non-Industry Players

Key geographical regions
• North America (US and Canada)
• Europe (UK, France, Germany, Spain, Italy, and rest of Europe)
• Asia-Pacific (China, Japan, India, and rest of Asia-Pacific / rest of the world)

For more information, please visit https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html

The Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030 report features the following companies, which we identified to be key players in this domain:

• 2bind
• Charles River Laboratories
• ChemAxon
• ComInnex
• Creative Biolabs
• Creative Biostructure
• CRELUX
• Domainex
• Evotec
• Red Glead Discovery
• SARomics Biostructures
• Shanghai ChemPartner
• Sygnature Discovery
• Vernalis Research

Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Current Market Landscape
5. Company Profiles: Fragment-based Drug Discovery Library and Service Providers
6. Partnerships and Collaborations
7. Key Acquisition Targets
8. Company Competitiveness Analysis
9. Cost Saving Analysis
10. Market Forecast and Opportunity Analysis
11. Executive Insights
12. Concluding Remarks
13. Appendix 1: Tabulated Data
14. Appendix 2: List of Companies and Organizations

For more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Roots Analysis
Phone 4158003415
Business Address Sacramento Los Angeles Beverly Hills
Country United States
Categories Business , Industry , Medical
Tags Fragment-Based Drug Discovery Solutions Market , Fragment-Based Drug Discovery Solutions Market Size , Fragment-Based Drug Discovery Solutions Market Share
Last Updated July 15, 2020